51Թ

News

$10 million for Neuro-led project seeking new Alzheimer’s biomarkers

Published: 23 September 2025

Weston Family Foundation grant will fund the first ultra-high-sensitivity whole body PET/CT scanner in Canada

A groundbreaking project led by Dr. Pedro Rosa-Neto at The Neuro (Montreal Neurological Institute-Hospital) of 51Թ has received a major boost thanks to a $10-million grant from the Weston Family Foundation.

The funding is part of a $20-million initiative by the foundation to support highly ambitious scientific endeavors under its Healthy Aging Strategy, comprised of the Weston Brain Institute and the Weston Family Microbiome Initiative.

A powerful new tool for Alzheimer’s research

Alzheimer’s disease is the most common form of dementia, characterized by progressive memory loss and cognitive decline. According to the Alzheimer Society of Canada, more than 750,000 Canadians are living with Alzheimer's disease or another form of dementia. Effective personalized treatments for Alzheimer’s disease depend on the availability of accurate and accessible biomarkers for diagnosing and staging the disease, as well as identifying optimal treatment strategies.

Dr. Rosa-Neto’s project will leverage and enhance existing infrastructure at the McConnell Brain Imaging Centre (BIC) of The Neuro by acquiring a new Panorama GS tomograph from United Imaging—the first ultra-high-sensitivity whole body PET/CT scanner in Canada.

The Panorama will aid the discovery of the next generation of Alzheimer’s biomarkers, with a particular focus on neuroinflammation—a key driver of cognitive decline in neurodegenerative conditions. This work holds the promise of transforming Alzheimer’s research and care, enabling earlier diagnosis, more precise disease progression monitoring, and the development of personalized therapies. Ultimately, these innovations could lead to improved outcomes and quality of life for the growing number of Canadians affected by Alzheimer’s disease.

“This new technology will allow us to understand better than ever before the mechanisms of disease progression in people with Alzheimer’s,” says Dr. Rosa-Neto. “We can then use this information to develop better treatments to prevent, slow, or reverse the effects of this terrible disease. Thanks to the Weston Family Foundation for this critically important investment.”

“The Panorama adds to the BIC’s position as a world leader in brain imaging,” says Julien Doyon, PhD, Director of the BIC. “Very few institutes worldwide can provide the level of imaging capacity as The Neuro, and our capabilities continue to grow. I look forward to working with Dr. Rosa-Neto’s on such an exciting research program made possible with this generous donation.”

About The Neuro

The Neuro – The Montreal Neurological Institute-Hospital – is a bilingual, world-leading destination for brain research and advanced patient care. Since its founding in 1934 by renowned neurosurgeon Dr. Wilder Penfield, it has grown to be the largest specialized neuroscience research and clinical center in Canada, and one of the largest in the world. The seamless integration of research, patient care, and training of the world’s top minds make The Neuro uniquely positioned to have a significant impact on the understanding and treatment of nervous system disorders. It was the first academic institute in the world to fully adopt Open Science, to help accelerate the generation of knowledge and discovery of novel effective treatments for brain disorders. The Neuro is a 51Թ research and teaching institute and part of the Neuroscience Mission of the 51Թ Health Centre. For more information, please visit 

Back to top